focus -WSS

focus

author：entertainment 2025-10-02 21:00:35 - browse：15

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Pandemic and All Hazards Preparedness Act needs lean update

knowledge

WSS

Biden administration begins canceling student loan debt for 804,000 borrowers

Biden administration begins canceling student loan debt for 804,000 borrowers

Eisai exec who led development of Alzheimer’s drug to retire

What to know about the judge who will handle the Trump case

Megan Rapinoe shares emotional post following US Women's World Cup exit

Swim instructor mom warns parents not to buy blue swimsuits for kids

Wikipedia

focus

entertainment

At least 13 dead in Texas as scorching temps continue

Indictment alleges Trump's ex

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Biogen’s boardroom scandal saddles CEO with first crisis

Cancer drug shortages should be causing more outrage

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Apple is now the first public company to be valued at $3 trillion

Parents surprise family after baby discharged from NICU after 170 days

At least 13 dead in Texas as scorching temps continue

Teachers share how revamped forgiveness program helped with their student loans

explore

Dozens dead from Maui wildfires: What we know about the victims

Biden’s NIH nominee is languishing in Congress

Recent heat wave in the Mediterranean caused by climate change: Study

BMS, looking to build heart drug business, turns to AI for diagnosis

White House announces new plan to address the growing threat of xylazine in overdose crisis

After Optum profits sink, UnitedHealth makes changes

entertainment

focus

knowledge

focus